Table 4.
Characteristics | n | Median Survival (Months) | P (Univariate) | P (Multivariate) RR [CI] |
---|---|---|---|---|
Sex | 0.45 | |||
Male | 93 | 8 | ||
Female | 74 | 8 | ||
Age (Years) | 0.58 | |||
< 60 | 85 | 8 | ||
≥ 60 | 82 | 8 | ||
Disease Presentation | 0.45 | |||
Synchronous | 52 | 7 | ||
Metachronous | 115 | 8 | ||
Location | 0.07 | |||
Colon | 123 | 8 | ||
Rectum | 44 | 7 | ||
Site of Metastases | 0.15 | |||
Peritoneum Only | 64 | 7 | ||
Peritoneum+Lung/Liver | 67 | 8 | ||
Peritoneum+Other | 36 | 9 | ||
Systemic Chemotherapy | 0.003 | |||
None | 83 | 5 | ||
5FU/L | 42 | 11 | ||
Modern | 42 | 12 | ||
Clinical Symptoms | < 0.001 | |||
Asymptomatic | 55 | 18 | ||
Mild | 78 | 6 | ||
Severe | 34 | 3 | ||
Extent of Carcinomatosis | 0.002 | |||
PCI < 10 | 103 | 6 | ||
PCI 10 to 20 | 47 | 11 | ||
PCI > 20 | 17 | 4 | ||
Histopathology | 0.003 | |||
Well Differentiated | 19 | 7 | ||
Moderately Differentiated | 89 | 11 | ||
Poorly Differentiated/Signet | 59 | 6 | ||
PSDSS Stage | 0.003 | 0.001 | ||
Stage I | 6 | 39 | 2.1 [1.3 - 4.9] | |
Stage II | 53 | 19 | ||
Stage III | 33 | 7 | ||
Stage IV | 75 | 4 | ||
PSDSS Stage | < 0.001 | < 0.001 | ||
Stage I/II | 59 | 22 | 2.8 [1.5 - 5.4] | |
Stage III/IV | 108 | 5 |